NCT03586518Recruiting
Validating Novel, Non-contrast Cardiac MRI Imaging in Haemodialysis Patients
Validating the Accuracy of Novel, Non-contrast, Cardiac Magnetic resOnaNce Imaging in Defining Myocardial FIbRosis in Patients With End-stage Renal Disease on haeModialysis: the CONFIRM Study
Source: ClinicalTrials.gov · Last updated 18 Apr 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
There are currently no good ways of measuring levels of scarring in the hearts of patients with advanced kidney disease and patients on dialysis, although recent research has shown a new cardiac MRI technique, called native T1 mapping, may provide a solution to this. To assess the accuracy of this novel technique in dialysis patients, it is essential to undertake a study which compares native T1 mapping to actual levels of scarring in the hearts of patients on dialysis.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 9 (estimated)
- First submitted
- 2 Jul 2018
- Start date
- 3 Nov 2019
- Primary completion date
- 31 Dec 2025
- Lead sponsor
- University of Leicester
- Diseases
- Chronic kidney disease
- NCT number
- NCT03586518
What you commit to
- Study type: Observational
- Planned participants: 9
- From 3 Nov 2019 to the primary completion date, 31 Dec 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Contraindication to MRI scan (e.g. pacemaker, incompatible metallic implants, claustrophobia)
Other
- Patients with expected or potential infiltrative cardiomyopathy (e.g. amyloidosis)
- Unable to give informed consent
- Unable to understand written and verbal explanations in English
Who the study is looking for
- Prevalent haemodialysis patient (more than 3 months)
- Active on the supportive care register with anticipated death in the subsequent 12 months
- Able to give informed consent
- Consent to donation of heart for research following death
- Able to understand written and verbal explanations in English
Age in the registry: 18 years to - · Sex: All
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| University Hospitals of Leicester NHS Trust Coordinator of this site? Confirm its status | Leicester | United Kingdom | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.